Cargando…

Prognostic impact of the tumor-infiltrating regulatory T-cell (Foxp3(+))/activated cytotoxic T lymphocyte (granzyme B(+)) ratio on resected left-sided pancreatic cancer

Among the subsets of tumor-infiltrating lymphocytes (TILs), activated cytotoxic T lymphocytes (granzyme B(+)) have an antitumor effect, while regulatory T lymphocytes [forkhead box P3 (Foxp3)(+)] suppress the antitumor immune response. The aim of the present study was to investigate the possible ass...

Descripción completa

Detalles Bibliográficos
Autores principales: Hwang, Ho Kyoung, Kim, Hyoung-Il, Kim, Se Hoon, Choi, Junjeong, Kang, Chang Moo, Kim, Kyung Sik, Lee, Woo Jung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5228542/
https://www.ncbi.nlm.nih.gov/pubmed/28105157
http://dx.doi.org/10.3892/ol.2016.5252
_version_ 1782493968029712384
author Hwang, Ho Kyoung
Kim, Hyoung-Il
Kim, Se Hoon
Choi, Junjeong
Kang, Chang Moo
Kim, Kyung Sik
Lee, Woo Jung
author_facet Hwang, Ho Kyoung
Kim, Hyoung-Il
Kim, Se Hoon
Choi, Junjeong
Kang, Chang Moo
Kim, Kyung Sik
Lee, Woo Jung
author_sort Hwang, Ho Kyoung
collection PubMed
description Among the subsets of tumor-infiltrating lymphocytes (TILs), activated cytotoxic T lymphocytes (granzyme B(+)) have an antitumor effect, while regulatory T lymphocytes [forkhead box P3 (Foxp3)(+)] suppress the antitumor immune response. The aim of the present study was to investigate the possible associations between TIL subsets and survival outcomes in patients with left-sided pancreatic ductal adenocarcinoma (PDAC). From January 2000 to December 2008, 30 patients who underwent curative distal pancreatectomy without neoadjuvant chemoradiotherapy due to left-sided PDAC were enrolled in the present study. TIL subsets were enumerated by immunohistochemical staining for cluster of differentiation (CD)3, CD4, CD8, Foxp3 and granzyme B in the intra-tumoral areas of tissue blocks. Patients were divided into two groups according to the median value of the absolute counts and relative ratios of TIL subsets. In the univariate analysis, age, gender, tumor size, nodal stage, tumor differentiation and lymphovascular/perineural invasion were not significantly associated with survival outcome. However, low levels of preoperative cancer antigen (CA) 19–9 were associated with a longer overall survival (OS), although the association was not significant (37 vs. 18 months; P=0.061). A high level of granzyme B(+) was associated with enhanced disease-free survival (DFS) (25 vs. 10 months; P=0.023), and a low Foxp3(+)/granzyme B(+) ratio was associated with a favorable prognosis in terms of DFS (25 vs. 8 months; P=0.008) and OS (47 vs. 17 months; P=0.003). In the multivariate analysis, the ratio of Foxp3(+)/granzyme B(+) was an independent prognostic factor for determining DFS [Exp(B), 3.060; 95% confidence interval (CI), 1.259–47.436; P=0.014] and OS [Exp(B), 3.580; 95% CI, 1.460–8.780; P=0.005]. Among the clinicopathological factors, low levels of CA 19–9 were significantly associated with a low Foxp3(+)/granzyme B(+) ratio (P=0.016). The results of the present study suggested that a low Foxp3(+)/granzyme B(+) ratio may be useful for predicting a good prognosis in surgically resected left-sided PDAC.
format Online
Article
Text
id pubmed-5228542
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-52285422017-01-19 Prognostic impact of the tumor-infiltrating regulatory T-cell (Foxp3(+))/activated cytotoxic T lymphocyte (granzyme B(+)) ratio on resected left-sided pancreatic cancer Hwang, Ho Kyoung Kim, Hyoung-Il Kim, Se Hoon Choi, Junjeong Kang, Chang Moo Kim, Kyung Sik Lee, Woo Jung Oncol Lett Articles Among the subsets of tumor-infiltrating lymphocytes (TILs), activated cytotoxic T lymphocytes (granzyme B(+)) have an antitumor effect, while regulatory T lymphocytes [forkhead box P3 (Foxp3)(+)] suppress the antitumor immune response. The aim of the present study was to investigate the possible associations between TIL subsets and survival outcomes in patients with left-sided pancreatic ductal adenocarcinoma (PDAC). From January 2000 to December 2008, 30 patients who underwent curative distal pancreatectomy without neoadjuvant chemoradiotherapy due to left-sided PDAC were enrolled in the present study. TIL subsets were enumerated by immunohistochemical staining for cluster of differentiation (CD)3, CD4, CD8, Foxp3 and granzyme B in the intra-tumoral areas of tissue blocks. Patients were divided into two groups according to the median value of the absolute counts and relative ratios of TIL subsets. In the univariate analysis, age, gender, tumor size, nodal stage, tumor differentiation and lymphovascular/perineural invasion were not significantly associated with survival outcome. However, low levels of preoperative cancer antigen (CA) 19–9 were associated with a longer overall survival (OS), although the association was not significant (37 vs. 18 months; P=0.061). A high level of granzyme B(+) was associated with enhanced disease-free survival (DFS) (25 vs. 10 months; P=0.023), and a low Foxp3(+)/granzyme B(+) ratio was associated with a favorable prognosis in terms of DFS (25 vs. 8 months; P=0.008) and OS (47 vs. 17 months; P=0.003). In the multivariate analysis, the ratio of Foxp3(+)/granzyme B(+) was an independent prognostic factor for determining DFS [Exp(B), 3.060; 95% confidence interval (CI), 1.259–47.436; P=0.014] and OS [Exp(B), 3.580; 95% CI, 1.460–8.780; P=0.005]. Among the clinicopathological factors, low levels of CA 19–9 were significantly associated with a low Foxp3(+)/granzyme B(+) ratio (P=0.016). The results of the present study suggested that a low Foxp3(+)/granzyme B(+) ratio may be useful for predicting a good prognosis in surgically resected left-sided PDAC. D.A. Spandidos 2016-12 2016-10-13 /pmc/articles/PMC5228542/ /pubmed/28105157 http://dx.doi.org/10.3892/ol.2016.5252 Text en Copyright: © Hwang et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Articles
Hwang, Ho Kyoung
Kim, Hyoung-Il
Kim, Se Hoon
Choi, Junjeong
Kang, Chang Moo
Kim, Kyung Sik
Lee, Woo Jung
Prognostic impact of the tumor-infiltrating regulatory T-cell (Foxp3(+))/activated cytotoxic T lymphocyte (granzyme B(+)) ratio on resected left-sided pancreatic cancer
title Prognostic impact of the tumor-infiltrating regulatory T-cell (Foxp3(+))/activated cytotoxic T lymphocyte (granzyme B(+)) ratio on resected left-sided pancreatic cancer
title_full Prognostic impact of the tumor-infiltrating regulatory T-cell (Foxp3(+))/activated cytotoxic T lymphocyte (granzyme B(+)) ratio on resected left-sided pancreatic cancer
title_fullStr Prognostic impact of the tumor-infiltrating regulatory T-cell (Foxp3(+))/activated cytotoxic T lymphocyte (granzyme B(+)) ratio on resected left-sided pancreatic cancer
title_full_unstemmed Prognostic impact of the tumor-infiltrating regulatory T-cell (Foxp3(+))/activated cytotoxic T lymphocyte (granzyme B(+)) ratio on resected left-sided pancreatic cancer
title_short Prognostic impact of the tumor-infiltrating regulatory T-cell (Foxp3(+))/activated cytotoxic T lymphocyte (granzyme B(+)) ratio on resected left-sided pancreatic cancer
title_sort prognostic impact of the tumor-infiltrating regulatory t-cell (foxp3(+))/activated cytotoxic t lymphocyte (granzyme b(+)) ratio on resected left-sided pancreatic cancer
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5228542/
https://www.ncbi.nlm.nih.gov/pubmed/28105157
http://dx.doi.org/10.3892/ol.2016.5252
work_keys_str_mv AT hwanghokyoung prognosticimpactofthetumorinfiltratingregulatorytcellfoxp3activatedcytotoxictlymphocytegranzymebratioonresectedleftsidedpancreaticcancer
AT kimhyoungil prognosticimpactofthetumorinfiltratingregulatorytcellfoxp3activatedcytotoxictlymphocytegranzymebratioonresectedleftsidedpancreaticcancer
AT kimsehoon prognosticimpactofthetumorinfiltratingregulatorytcellfoxp3activatedcytotoxictlymphocytegranzymebratioonresectedleftsidedpancreaticcancer
AT choijunjeong prognosticimpactofthetumorinfiltratingregulatorytcellfoxp3activatedcytotoxictlymphocytegranzymebratioonresectedleftsidedpancreaticcancer
AT kangchangmoo prognosticimpactofthetumorinfiltratingregulatorytcellfoxp3activatedcytotoxictlymphocytegranzymebratioonresectedleftsidedpancreaticcancer
AT kimkyungsik prognosticimpactofthetumorinfiltratingregulatorytcellfoxp3activatedcytotoxictlymphocytegranzymebratioonresectedleftsidedpancreaticcancer
AT leewoojung prognosticimpactofthetumorinfiltratingregulatorytcellfoxp3activatedcytotoxictlymphocytegranzymebratioonresectedleftsidedpancreaticcancer